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Background
Patient recruitment is one of the main challenges in
conducting randomised controlled trials (RCTs).
Patients’ treatment preferences are viewed as a barrier
to RCT recruitment yet there is little research to under-
stand them. This study explored the expression of pre-
ferences by potential trial recruits, the response to them
by recruiters, and their influence on trial participation
decisions during trial recruitment appointments.
Methods
We undertook an analysis of audio recordings of conse-
cutive recruitment appointments to a UK multi-centre
RCT of three different treatments for prostate cancer
(the ProtecT - Prostate cancer testing and Treatment -
study) over a three month period. 93/108 appointments
with men aged 51-70 years were recorded successfully
and analysed using techniques of content and thematic
analysis.
Results
Most potential participants expressed a desire for a par-
ticular treatment early in appointments, with their
desires ranging on a continuum from hesitant to well-
formed opinions. Recruiters explored these initial treat-
ment views in the context of evidence-based treatment
and study information which resulted in many men
becoming uncertain about their initial views and open
to RCT recruitment, often accepting a different treat-
ment from their original ‘preference’. Only a quarter of
men who initially expressed a wish for a particular treat-
ment sustained or developed a clear treatment prefer-
ence as the consultation proceeded and ultimately
received this treatment. In most of these cases the
recruiters established the rationale for the preference
then provided specific information that counter-
balanced their reasoning by emphasising the position of
clinical equipoise, uncertainty of the prognosis and the
pros and cons of their desired and non desired treat-
ment. This counter-balancing of information continued
until they were sufficiently satisfied that the man was
making a fully informed decision.
Conclusions
Many potential trial recruits will present initially with a
treatment preference at trial recruitment but most of
these preferences will dissolve after thorough explora-
tion and targeted evidence-based information enabling
trial participation. Only a minority of preferences are
upheld after specific counter-balancing of information is
tactfully given. The key for future research is to con-
tinue developing strategies that sensitively elicit and
explore treatment preferences so that the more robust
preferences can be distinguished from the ephemeral
views to maximise trial recruitment.
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